620 related articles for article (PubMed ID: 17475943)
1. Prednisolone does not reduce withdrawal headache: a randomized, double-blind study.
Bøe MG; Mygland A; Salvesen R
Neurology; 2007 Jul; 69(1):26-31. PubMed ID: 17475943
[TBL] [Abstract][Full Text] [Related]
2. How to treat medication-overuse headache: prednisolone or no prednisolone?
Diener HC
Neurology; 2007 Jul; 69(1):14-5. PubMed ID: 17606877
[No Abstract] [Full Text] [Related]
3. Management of medication overuse headache: 1-year randomized multicentre open-label trial.
Hagen K; Albretsen C; Vilming ST; Salvesen R; Grønning M; Helde G; Gravdahl G; Zwart JA; Stovner LJ
Cephalalgia; 2009 Feb; 29(2):221-32. PubMed ID: 18823363
[TBL] [Abstract][Full Text] [Related]
4. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs.
Rossi P; Di Lorenzo C; Faroni J; Cesarino F; Nappi G
Cephalalgia; 2006 Sep; 26(9):1097-105. PubMed ID: 16919060
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
6. Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study.
Rossi P; Faroni JV; Nappi G
Cephalalgia; 2008 Nov; 28(11):1196-200. PubMed ID: 18727648
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness.
Zeeberg P; Olesen J; Jensen R
Cephalalgia; 2006 Oct; 26(10):1192-8. PubMed ID: 16961785
[TBL] [Abstract][Full Text] [Related]
8. Medication overuse headache and chronic migraine in a specialized headache centre: field-testing proposed new appendix criteria.
Zeeberg P; Olesen J; Jensen R
Cephalalgia; 2009 Feb; 29(2):214-20. PubMed ID: 18823364
[TBL] [Abstract][Full Text] [Related]
9. Probable medication-overuse headache: the effect of a 2-month drug-free period.
Zeeberg P; Olesen J; Jensen R
Neurology; 2006 Jun; 66(12):1894-8. PubMed ID: 16707727
[TBL] [Abstract][Full Text] [Related]
10. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
12. [Long-term prognosis of analgesics abuse headache].
Takase Y; Kishigami H; Nakano M; Tatsumi C
Rinsho Shinkeigaku; 2005 Sep; 45(9):629-33. PubMed ID: 16248393
[TBL] [Abstract][Full Text] [Related]
13. Similarities and differences between chronic migraine and episodic migraine.
Ferrari A; Leone S; Vergoni AV; Bertolini A; Sances G; Coccia CP; Ottani A; Pinetti D; Sternieri E
Headache; 2007 Jan; 47(1):65-72. PubMed ID: 17355496
[TBL] [Abstract][Full Text] [Related]
14. Prednisone vs. placebo in withdrawal therapy following medication overuse headache.
Pageler L; Katsarava Z; Diener HC; Limmroth V
Cephalalgia; 2008 Feb; 28(2):152-6. PubMed ID: 18039339
[TBL] [Abstract][Full Text] [Related]
15. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
[TBL] [Abstract][Full Text] [Related]
17. Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up.
Grazzi L; Andrasik F; D'Amico D; Usai S; Kass S; Bussone G
Headache; 2004; 44(7):678-83. PubMed ID: 15209690
[TBL] [Abstract][Full Text] [Related]
18. Medication overuse headache.
Obermann M; Bartsch T; Katsarava Z
Expert Opin Drug Saf; 2006 Jan; 5(1):49-56. PubMed ID: 16370955
[TBL] [Abstract][Full Text] [Related]
19. Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study.
Rabe K; Pageler L; Gaul C; Lampl C; Kraya T; Foerderreuther S; Diener HC; Katsarava Z
Cephalalgia; 2013 Feb; 33(3):202-7. PubMed ID: 23093541
[TBL] [Abstract][Full Text] [Related]
20. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
Goadsby PJ
Cephalalgia; 2008 Sep; 28 Suppl 2():36-41. PubMed ID: 18715331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
